-
Prospective validation of imaging and serum diagnostic biomarkers of steatohepatitis and fibrosis in MASLD: the LITMUS Imaging Study
Pavlides, M., Vali, Y., Mózes, F. E., Wonders, K., Akhtar, S., Hockings, P. D., Shumbayawonda, E., Pepin, K., Fernandez-Lizaranzu, I., Leeming, D. J., Cobbold, J. F., Allison, M. E. D., Aithal, G. P., Romero-Gomez, M., Aller, R., Pericàs, J. M., Boursier, J. R., Petta, S., Schattenberg, J. R. M. & Ekstedt, M. & 21 others, , Aug 2026, In: Nature Medicine. 32, 8, p. 2959-2969 11 p.Research output: Contribution to Journal › Article › Academic › peer-review
-
HELIOT: LLM-Based CDSS for adverse drug reaction management
de Vito, G., Ferrucci, F. & Angelakis, A., 25 Oct 2025, In: Knowledge-Based Systems. 328, 114184.Research output: Contribution to Journal › Article › Academic › peer-review
-
Extracellular vesicles as biomarkers for metabolic dysfunction-associated steatotic liver disease staging using explainable artificial intelligence
Trifylli, E. M., Angelakis, A., Kriebardis, A. G., Papadopoulos, N., Fortis, S. P., Pantazatou, V., Koskinas, J., Kranidioti, H., Koustas, E., Sarantis, P., Manolakopoulos, S. & Deutsch, M., 14 Jun 2025, In: World Journal of Gastroenterology. 31, 22, 106937.Research output: Contribution to Journal › Article › Academic › peer-review
- All publications
